These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34633275)

  • 1. Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Liao D; Liu X; Yuan X; Feng P; Ouyang Z; Liu Y; Li C
    Gynecol Endocrinol; 2022 Feb; 38(2):110-115. PubMed ID: 34633275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Probiotic Supplementation on Clinical Symptom, Weight Loss, Glycemic Control, Lipid and Hormonal Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Tabrizi R; Ostadmohammadi V; Akbari M; Lankarani KB; Vakili S; Peymani P; Karamali M; Kolahdooz F; Asemi Z
    Probiotics Antimicrob Proteins; 2022 Feb; 14(1):1-14. PubMed ID: 31165401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review.
    Maleki V; Jafari-Vayghan H; Kashani A; Moradi F; Vajdi M; Kheirouri S; Alizadeh M
    Gynecol Endocrinol; 2019 Jun; 35(6):463-469. PubMed ID: 30806529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Foroozanfard F; Kavossian E; Kia M; Aghadavod E; Amirani E; Asemi Z
    Biol Trace Elem Res; 2020 Feb; 193(2):334-341. PubMed ID: 30977089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Gong Y; Jiang T; He H; Wang Y; Wu GL; Shi Y; Cai Q; Xiong CL; Shen R; Li J
    Clin Endocrinol (Oxf); 2023 May; 98(5):682-691. PubMed ID: 36746677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the effects of probiotic supplementation on glycemia, lipidic profiles, weight loss and C-reactive protein in women with polycystic ovarian syndrome.
    Liao D; Zhong C; Li C; Mo L; Liu Y
    Minerva Med; 2018 Dec; 109(6):479-487. PubMed ID: 30256077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
    Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
    Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Kazemi M; Hadi A; Pierson RA; Lujan ME; Zello GA; Chilibeck PD
    Adv Nutr; 2021 Feb; 12(1):161-178. PubMed ID: 32805007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
    Chien YJ; Chang CY; Wu MY; Chen CH; Horng YS; Wu HC
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Mohd Shukri MF; Norhayati MN; Badrin S; Abdul Kadir A
    PeerJ; 2022; 10():e13992. PubMed ID: 36132218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Tea Consumption on Anthropometric Parameters, Metabolic Indexes and Hormone Levels of Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen W; Pan Y; Jin B; Zhang Z; You T; Qu Y; Han M; Yuan X; Zhang Y
    Front Endocrinol (Lausanne); 2021; 12():736867. PubMed ID: 34966355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Ebrahimi FA; Rahimi M; Tajbakhsh B; Asemi Z
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):851-7. PubMed ID: 26666519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M
    Horm Metab Res; 2018 Mar; 50(3):193-200. PubMed ID: 29523006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Zhou J; Zuo W; Tan Y; Wang X; Zhu M; Zhang H
    J Ovarian Res; 2023 Mar; 16(1):54. PubMed ID: 36932420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials.
    Moslehi N; Zeraattalab-Motlagh S; Rahimi Sakak F; Shab-Bidar S; Tehrani FR; Mirmiran P
    Nutr Rev; 2023 Apr; 81(5):555-577. PubMed ID: 36099162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.
    Maleki V; Izadi A; Farsad-Naeimi A; Alizadeh M
    Nutr Res; 2018 Aug; 56():1-10. PubMed ID: 30055769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis.
    Heydarpour F; Hemati N; Hadi A; Moradi S; Mohammadi E; Farzaei MH
    J Ethnopharmacol; 2020 May; 254():112741. PubMed ID: 32151755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
    Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of vitamin D supplementation on lipid levels in polycystic ovary syndrome patients: a meta-analysis of randomized controlled trials.
    Jin B; Qian L; Fu X; Zhu J; Shu J
    J Int Med Res; 2020 Aug; 48(8):300060520935313. PubMed ID: 32776821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Fathizadeh H; Milajerdi A; Reiner Ž; Kolahdooz F; Chamani M; Amirani E; Asemi Z
    Curr Pharm Des; 2019; 25(30):3266-3281. PubMed ID: 31470778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.